Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Sex hormones do not cause oral lichen planus.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Red Ginseng Extract may help human hair grow by activating growth pathways and blocking negative effects of certain hormones.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

TRH stimulates human hair growth and extends the hair growth phase.

SHBG may be a useful early indicator and treatment target for PCOS.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Different hair loss patterns may be linked to varying male hormone levels.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Prolactin affects when mice shed and grow hair.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.